camostat has been researched along with Hepatitis, Chronic in 1 studies
camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a case of autoimmune hepatitis (AIH) that may have occurred following drug-induced liver injury with camostat mesilate and/or benzbromarone in an elderly patient." | 1.43 | Autoimmune hepatitis following drug-induced liver injury in an elderly patient. ( Arai, M; Haga, Y; Iino, Y; Kanda, T; Kumagai, J; Nakamoto, S; Nakamura, M; Sasaki, R; Wu, S; Yasui, S; Yokosuka, O, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumagai, J | 1 |
| Kanda, T | 1 |
| Yasui, S | 1 |
| Haga, Y | 1 |
| Sasaki, R | 1 |
| Nakamura, M | 1 |
| Wu, S | 1 |
| Nakamoto, S | 1 |
| Arai, M | 1 |
| Iino, Y | 1 |
| Yokosuka, O | 1 |
1 other study available for camostat and Hepatitis, Chronic
| Article | Year |
|---|---|
Autoimmune hepatitis following drug-induced liver injury in an elderly patient.
Topics: Aged; Benzbromarone; Biopsy; Chemical and Drug Induced Liver Injury; Esters; Gabexate; Guanidines; H | 2016 |